Standout Papers

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma 2009 2026 2014 2020 6.2k
  1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma (2009)
    Tony Mok, Yi‐Long Wu et al. New England Journal of Medicine

Immediate Impact

18 from Science/Nature 168 standout
Sub-graph 1 of 14

Citing Papers

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Lung cancer
2021 Standout
81 intermediate papers

Works of Baohui Han being referenced

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout

Author Peers

Author Last Decade Papers Cites
Baohui Han 4288 5402 1676 10 6.4k
Jin-Ji Yang 5061 6454 1977 12 7.5k
Benjamin Margono 4445 5702 1711 6 6.7k
Busyamas Chewaskulyong 4259 5373 1645 20 6.3k
Emma Duffield 5660 7088 2029 21 8.3k
José Rodrigues Pereira 6203 6929 1967 25 8.6k
Paula Herman 4669 5435 3417 13 8.2k
J. Guillermo Paez 4680 5372 3530 9 8.5k
Serban Ghiorghiu 3957 4986 1791 30 5.7k
Sean Tracy 5019 5535 3126 19 8.1k
D. Johnston 3500 3578 1096 22 5.0k

All Works

Loading papers...

Rankless by CCL
2026